Back
US Global GO GOLD and Prec Mtl Mnrs ETF Vs. Spyre Therapeutics Industry Stock Comparison
Buy
62
GOAU
US Global GO GOLD and Prec Mtl Mnrs ETF
Last Price:
18.70
Seasonality Move:
-0.81%
Sell
27
SYRE
Spyre Therapeutics
Last Price:
23.13
Seasonality Move:
49.76%
Buy
62
US Global GO GOLD and Prec Mtl Mnrs ETF (GOAU)
is a Buy
Is US Global GO GOLD and Prec Mtl Mnrs ETF a Buy, Sell or Hold?
- The current US Global GO GOLD and Prec Mtl Mnrs ETF [GOAU] share price is $18.86. The Score for GOAU is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- GOAU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $22.90. The Score for SYRE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GOAU Stock Price Chart
What is US Global GO GOLD and Prec Mtl Mnrs ETF's stock price today?
-
The US Global GO GOLD and Prec Mtl Mnrs ETF share price today is $18.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOAU is experiencing selling pressure, which indicates risk of future bearish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $22.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
GOAU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 42.6 | Sell |
Chaikin Money Flow: | -26069 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.14 - 20.48) | Sell |
Bollinger Bands (100): | (16.04 - 19.9) | Buy |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 28.27 | Sell |
Chaikin Money Flow: | -408420 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.66 - 36.8) | Sell |
Bollinger Bands (100): | (27.1 - 39.22) | Sell |
GOAU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.2 | Sell |
20-day SMA: | 19.62 | Sell |
50-day SMA: | 19.52 | Sell |
200-day SMA: | 16.93 | Buy |
8-day EMA: | 19.27 | Sell |
20-day EMA: | 19.47 | Sell |
50-day EMA: | 19.24 | Sell |
200-day EMA: | 17.65 | Buy |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.49 | Sell |
20-day SMA: | 31.58 | Sell |
50-day SMA: | 33.73 | Sell |
200-day SMA: | 24.46 | Sell |
8-day EMA: | 26.49 | Sell |
20-day EMA: | 30.15 | Sell |
50-day EMA: | 32.53 | Sell |
200-day EMA: | 27.05 | Sell |
US Global GO GOLD and Prec Mtl Mnrs ETF Earnings Growth & GOAU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
US Global GO GOLD and Prec Mtl Mnrs ETF Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |